Appendix B: Panel Roster and Financial Disclosures
PML/JCV
| Member | Institution | Financial Disclosure | |
|---|---|---|---|
| Company | Relationship | ||
| Shruti Agnihotri | The University of Alabama at Birmingham Marnix E. Heersink School of Medicine | Moderna Pfizer Gilead Sciences Johnson & Johnson |
Equity Interest |
| Paola Cinque | San Raffaele Scientific Institute, Milan, Italy | Janssen | Consultant |
| Cellevolve | Scientific Advisory Board | ||
| Gilead Sciences ViiV Healthcare |
Research Support (paid to institution) | ||
| David Clifford* | Washington University School of Medicine in St. Louis | Roche Takeda Seattle Genetics Arena Pharmaceuticals |
Scientific Advisory Board |
|
Wave Life Sciences Excision BioTherapeutics, Inc. Sanofi Genzyme Atara Biotherapeutics, Inc. |
Data Safety Monitoring Board | ||
| Irene Cortese | National Institutes of Health | Nouscom AG Keires AG PDC*line Pharma Life Sciences Partners CV |
Equity Interest |
| Christina Marra | University of Washington School of Medicine | None | N/A |
| Jose M. Miro | Hospital Clinic-IDIBAPS, University of Barcelona, Spain | None | N/A |
| * Section Group Lead Note: Members are required to update disclosures annually and to notify guideline staff of any relevant changes in status during the interim. |
|||
Download Guidelines
- Section Only PDF (52.64 KB)
- Full Guideline PDF (6.03 MB)
- Tables Only PDF (1.18 MB)